VotedBy VotedBy ⌕
Election Day · Tue, Nov 3See how your members of Congress voted →

H.R. 460 · 113th Congress

Patients' Access to Treatments Act of 2013

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Never voted on. It didn't reach a floor vote before the 113th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

DMR McKinleySponsor
142 cosponsors · 110 D, 32 R
SBD Bonamici JCD Conyers LCD Capps ACR Crenshaw SCR Capito DCD Cicilline PDD DeFazio SFD Farr JMD Moran MMD Michaud CPD Pingree CRD Rangel JRR Runyan PTD Tonko FWR Wolf CYR Young TDD Deutch RHD Holt MCR Coffman JLD Lewis GMD Moore END Norton DYR Young WCD Clay JLD Langevin EMD Markey LRD Roybal-Allard CSD Shea-Porter JTD Tierney KED Ellison SID Israel LSD Slaughter JBD Brownley GCD Connolly DPD Price IRR Ros-Lehtinen TRR Rooney JGR Gerlach PWD Welch MTD Takano SDD Davis WKD Keating DSD Scott GHR Harper WED Enyart PKR King SBD Bishop BBD Braley MPD Pocan DTD Titus JHD Huffman RWR Wittman SLD Lynch DLD Loebsack BMD McCollum JMD McGovern TBD Bishop NTD Tsongas ECD Cummings TLR Latham TRD Ryan BSD Scott BTD Thompson KCD Castor SCD Cohen AED Eshoo JKD Kennedy ZLD Lofgren HJD Johnson MLD Lujan Grisham EPD Perlmutter LFD Frankel SBR Bachus EJD Johnson BLD Lee DPD Payne DKD Kildee JSD Speier TPR Poe ASD Schiff ASD Schwartz JGD Garamendi MAR Amodei CMD McCarthy CGR Gibson RFR Frelinghuysen BLD Luján MCD Cartwright JBD Beatty NVD Velázquez LBR Barletta JCD Carney FSR Sensenbrenner SSR Stivers MDD Doyle JHR Heck TMR Murphy SMD Maloney RBD Brady RGD Grijalva JGD Garcia EPD Pastor MQD Quigley DJR Jolly MFR Fitzpatrick KBD Bass MHD Honda DMD Matsui EBD Blumenauer KCD Clark TGD Gabbard AHD Hastings RHD Hinojosa LLR Lance ACD Carson RKD Kelly GMD Meng ESD Swalwell CVD Van Hollen GGD Green BHD Higgins CMD Maloney SPD Peters GKD Butterfield TCD Cárdenas LDD Doggett BSD Schneider HCR Coble MGR Grimm AKD Kuster BOD O’Rourke ERR Royce TWD Walz JCD Costa RHR Hall CPD Peterson CSR Smith BRD Rush RND Nolan KSD Sinema AKD Kirkpatrick MTD Thompson

16 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

Patients' Access to Treatments Act of 2013 - Amends the Public Health Service Act to establish cost-sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost-sharing structure.

What it does: CRS summary · Introduced in House · Feb 4, 2013

Patients' Access to Treatments Act of 2013 - Amends the Public Health Service Act to establish cost-sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost-sharing structure. Prohibits such a health plan from imposing cost-sharing requirements, including co-payment and co-insurance, applicable to prescription drugs in a specialty drug tier that exceed the dollar amount of cost-sharing requirements applicable to prescription drugs in a non-preferred brand drug tier. Applies the non-preferred brand drug tier for which beneficiary cost-sharing is lowest, if a formulary used by the health plan contains more than one non-preferred brand drug tier.

Defines: (1) "non-preferred brand drug tier" as a category of prescription drugs within a tier in a formulary for which beneficiary cost-sharing is greater than tiers for generic drugs or preferred brand drugs, and that are not included within a specialty drug tier; and (2) "specialty drug tier" as a category of prescription drugs within a tier in a formulary for which beneficiary cost-sharing is greater than tiers for generic drugs, preferred brand drugs, or non-preferred drugs in the plan's formulary.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: Patients' Access to Treatments Act of 2013

Latest action (Feb 8, 2013): Referred to the Subcommittee on Health.

Policy area: Health · Origin: House · Introduced: Feb 4, 2013

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.